A research trial that could stop millions of women from developing cervical cancer | Latest News

Excellent care with compassion strapline

together Excellent care with compassion

A research trial that could stop millions of women from developing cervical cancer | Latest News

A research trial that could stop millions of women from developing cervical cancer

Our Oncology and Research teams are working in partnership with The University of Manchester and Douglas Pharmaceuticals to develop a new treatment of early-stage cervical cancer.

The research is looking into whether a drug, commonly used to treat HIV, might prevent early-stage cervical cancer.

Dr. Pierre Martin-Hirsch, our Consultant Gynaecological Oncologist and Director of Research will be leading the clinical trial in the UK; he said: “This is a really exciting project and something that I am incredibly proud to be involved in. This new treatment could offer hope for millions of women across the world who are at risk of cervical cancer.

A clinical trial to try and develop this treatment is due to start in early 2018.

We have placed cookies on your computer to help make this website better. You can at any time read our cookie policy. Otherwise, we will assume that you're OK to continue.

Change cookie settings: